CN Bio appoints Dr. Tomasz Kostrzewski as Chief Scientific Officer

CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the appointment of Dr. Tomasz Kostrzewski as Chief Scientific Officer.

Across North Carolina, medical debt exacts a heavy toll

On March 30, 2019, a swerving car upended Tom Burke’s life.

September 23, 2024

First gene therapy trial aims to restore hearing in children

The aim of this clinical trial, which has just received approval in France, is to assess the safety and efficacy of a new gene therapy

February 5, 2024

UCB’s BIMZELX gains FDA approval for inflammatory conditions

The product is indicated to treat active psoriatic arthritis, non-radiographic axial spondyloarthritis and ankylosing spondylitis. Credit: Oporty786/Shutterstock. Biopharmaceutical company UCB has received US Food and

September 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.